Escalating Doses of Memantine in Down Syndrome (MEDS-123)
NCT07531940
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Down Syndrome
Intellectual Disability
Interventions
DRUG:
Memantine
Sponsor
University Hospitals Cleveland Medical Center